Gelonghui, April 8, 丨 Mengke Pharmaceutical (688373.SH) announced that as of April 8, 2024, the increase holder had accumulated 269,800 shares of the company's shares through centralized bidding through the Shanghai Stock Exchange trading system, accounting for 0.04% of the company's total share capital. The total amount of increase in holdings was 13.297.39 million yuan, which has exceeded 50% of the lower limit of 500,000 shares in this increase plan. The implementation of this holdings increase plan has not yet been completed, and the entities that have increased their holdings will continue to implement the holdings increase in accordance with the holdings increase plan.
The shareholders, directors and senior management personnel of at least 5% of the shareholders, directors and senior management personnel include: MICURX (HK) LIMITED (hereinafter referred to as “Mengke Hong Kong”), the company's chairman and general manager, Mr. Li Zhile (Yuan Zhengyu), the company's director, deputy general manager, chief financial officer and board secretary, Mr. Wang Xinghai, the company's deputy general manager, and Mr. Zhao Dongming, the company's deputy general manager.